Literature DB >> 4102550

Dexamethasone treatment in herpes-simplex encephalitis.

A R Upton, J B Foster, D D Barwick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4102550     DOI： 10.1016/s0140-6736(71)91534-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities.

Authors:  Uta K Meyding-Lamadé; Christoph Oberlinner; Philipp R Rau; Sonja Seyfer; Sabine Heiland; Johann Sellner; Brigitte T Wildemann; Wolfram R Lamadé
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

Review 2.  Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.

Authors:  Michael J Bradshaw; Arun Venkatesan
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

3.  The Interleukin-1 Balance During Encephalitis Is Associated With Clinical Severity, Blood-Brain Barrier Permeability, Neuroimaging Changes, and Disease Outcome.

Authors:  Benedict Daniel Michael; Michael J Griffiths; Julia Granerod; David Brown; Geoff Keir; Małgorzata Wnęk; Daniel J Cox; Rishma Vidyasagar; Ray Borrow; Laura M Parkes; Tom Solomon
Journal:  J Infect Dis       Date:  2015-12-27       Impact factor: 5.226

4.  The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trial.

Authors:  U Meyding-Lamadé; C Jacobi; F Martinez-Torres; T Lenhard; B Kress; M Kieser; C Klose; K Einhäupl; J Bösel; M-B Mackert; V Homberg; C Koennecke; G Weißheit; D Claus; B Kieseier; J Bardutzky; T Neumann-Haefelin; M W Lorenz; H Steinmetz; C Gerloff; D Schneider; A Grau; M Klein; R Dziewas; U Bogdahn; W Jakob; R Linker; K Fuchs; A Sander; S Luntz; T Hoppe-Tichy; D F Hanley; R von Kummer; E Craemer
Journal:  Neurol Res Pract       Date:  2019-09-12

5.  Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933].

Authors:  Francisco Martinez-Torres; Sanjay Menon; Maria Pritsch; Norbert Victor; Ekkehart Jenetzky; Katrin Jensen; Eva Schielke; Erich Schmutzhard; Jan de Gans; Chin-Hee Chung; Steffen Luntz; Werner Hacke; Uta Meyding-Lamadé
Journal:  BMC Neurol       Date:  2008-10-29       Impact factor: 2.474

6.  Fulminant Herpes Simplex Virus Type I Encephalitis Despite Maximal Medical Therapy.

Authors:  Nakul Katyal; Ather M Taqui; Deborah Tepper; Jonathan M Beary; Christopher R Newey
Journal:  Cureus       Date:  2018-04-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.